NAMMembership

Our Members

The National Academy of Medicine has more than 2,400 members elected in recognition of outstanding professional achievement. Members contribute to the work of the NAM and the National Academies through volunteer service on leadership and advisory bodies and programmatic working groups. The NAM elects no more than 90 members from the United States and 10 international members annually.

Member Login
Member Directory
[Membership] is an unparalleled opportunity to meet and interact with colleagues who are pushing the boundaries of scientific and medical innovation with a common goal: to understand and treat disease and promote health worldwide.
Eva Feldman
MD, PhD, Class of 2014
Newly Elected Class
Election Criteria and Process
Membership Sections
Code of Conduct

Pioneers of Progress

Congratulations to Our Nobel Prize Winners

More than 80 members of the NAM are recipients of Nobel Prizes in physiology or medicine; chemistry; economics; physics, and peace. In 2023, Katalin Karikó (Class of 2022) and Drew Weissman (Class of 2022) received the Nobel Prize in Physiology or Medicine for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

View All Nobel Prize Winners

Volunteerism

Member Awards for Service to the NAM

Each year, the NAM issues three awards to members in recognition of outstanding contributions to the work of the Academy. The Walsh McDermott Medal recognizes distinguished service over an extended period of time; the Adam Yarmolinsky Medal recognizes members from disciplines outside the health and medical sciences; and the David Rall Medal recognizes exemplary leadership as an activity chair. Nominations open each July.

Learn More

At a Glance

Members by the Numbers

2,400+

Members

43

Major fields of biomedical science, health, 
and medicine

41

Countries

NAM Officers and Council

The Council is the NAM’s governing and oversight body. Councilors are 
elected by NAM members.

Monica Bertagnolli
President, National Academy of Medicine; Chair, NAM Council

Monica M. Bertagnolli, MD, is the President of the National Academy of Medicine (NAM) and Chair of the NAM Council. A surgical oncologist and physician-scientist, her research has advanced understanding of the role of genetics and inflammation in gastrointestinal cancers and soft-tissue sarcomas. She served as director of the National Cancer Institute before becoming director of the NIH and earlier held academic and clinical leadership roles at Harvard Medical School/Brigham and Women’s Hospital and Dana-Farber Brigham Cancer Center. A past president and chair of the board of directors for the American Society of Clinical Oncology, she has also served on the boards of the American Cancer Society and the Prevent Cancer Foundation.

Bertagnolli has championed collaborative efforts to build a learning health system by transforming the data infrastructure for clinical research, including by spearheading the mCODE initiative, which enabled standardized oncology data exchange, and DataCOUNTS, an NIH program managing data to drive a learning health system. She is also a strong advocate for increasing the representation of clinical trial participants, particularly from rural and remote communities.

A native of rural Wyoming, Bertagnolli was elected as a member of the National Academy of Medicine in 2021. She is the first woman to serve as president of the NAM since its establishment as the Institute of Medicine in 1970.

The daughter of first-generation Italian and French Basque immigrants, Dr. Bertagnolli grew up on a ranch in southwestern Wyoming. She graduated from Princeton University with a Bachelor of Science in Engineering degree and attended medical school at the University of Utah. She trained in surgery at Brigham and Women’s Hospital and was a research fellow in tumor immunology at the Dana-Farber Cancer Institute.

NAM Council Vice Chair; Professor and Former Dean, Woodruff School of Nursing
Emory University
Michele Barry, MD. FACP, FASTMH
Senior Associate Dean for Global Health; Director of the Stanford Center for Innovation in Global Health
Stanford University
Dean, Wake Forest University School of Medicine; Chief Academic Officer, Advocate Health
Annual Meeting PANEL MODERATOR

Ebony Boulware, MD, MPH, is Dean of Wake Forest University School of Medicine, Executive Vice President for Academic Health Affairs at Wake Forest University, and Chief Academic Officer for Advocate Health. She leads the academic mission for one of the nation’s largest integrated academic health systems, providing strategic leadership for education, research, faculty affairs, and academic innovation across a six-state organization. Dr. Boulware is a general internist, physician-scientist, and clinical epidemiologist whose research has advanced understanding of the patient-, clinician-, health system-, and community-level factors that shape health outcomes and health equity. Her work has informed national policy, influenced clinical practice, and advanced the translation of scientific discovery into improved health through innovations in research, education, and health system transformation. Dr. Boulware serves on the Governing Council of the National Academy of Medicine and is an elected member of the American Society for Clinical Investigation, the Association of American Physicians, and the American Academy of Arts and Science.

Ana M. Cauce, PhD
Professor of Psychology
University of Washington
President
University of Minnesota System
Distinguished Professor of Medicine, David Geffen School of Medicine; Distinguished Professor of Health Policy and Management, Fielding School of Public Health; Executive Vice Chair for Academic Affairs, Department of Medicine, University of California, Los Angeles
Russell N. DeJong Professor of Neurology; James W. Albers Distinguished University Professor; Director, ALS Center of Excellence, University of Michigan Health System
Scott Gottlieb, MD
Senior Fellow
American Enterprise Institute
Robert and Janice McNair Endowed Chair in Molecular and Human Genetics, Professor and Chair
Baylor College of Medicine

Brendan Lee, MD, PhD, is Professor and Chairman of the Department of Molecular and Human Genetics at Baylor College of Medicine. As a physician scientist, he studies structural birth defects, inborn errors of metabolism, and genomic medicine implementation. He leads multiple NIH clinical research consortia and holds multiple patents in therapeutics. Licensed technologies are in industry-sponsored clinical development for osteoarthritis, Osteogenesis Imperfecta, and Maple Syrup Urine Disease. He has served on multiple advisory panels including on the Advisory Committee to the Director of the NIH. He was an HHMI Investigator prior to becoming Chairman of the DMHG in 2014. The DMHG is a hybrid clinical/basic science/molecular pathology department ranking first in NIH funding for 14 consecutive years among US genetics departments. He also founded Baylor Genetics, a unique academic-commercial joint venture genetic diagnostic laboratory who was among the first to implement clinical multi-omic analyses.

Dean, Graduate School of Public Health, Jonas Salk Professor of Population Health, Professor of Environmental and Occupational Health, University of Pittsburgh
Distinguished Professor of Sociology
Indiana University
Chair, Human Oncology and Pathogenesis Program
Memorial Sloan Kettering Cancer Center
Dean of Population Health Sciences, David Cohen Chair and Professor of Primary Health Care and Population Health
University College London
President and CEO
Memorial Sloan Kettering Cancer Center
President and Vice Chair
OPKO Health, Inc.

Elias Zerhouni, MD, is Professor Emeritus of Radiology and Biomedical Engineering at Johns Hopkins University in Baltimore, Maryland. He currently serves as Vice Chairman and President of OPKO Health. From 2011 to 2018, he was President of Global Research & Development and a member of the Executive Committee at Sanofi. At Johns Hopkins, he held several leadership roles including Chair of the Department of Radiology, Vice Dean for Research, and Executive Vice Dean of the School of Medicine. In 2002, he was appointed Director of the National Institutes of Health, where he oversaw 27 Institutes and Centers, more than 18,000 employees, and a $29.5 billion budget. In 2009, President Obama named him one of the first U.S. presidential science envoys. Dr. Zerhouni also served as a senior fellow with the Bill and Melinda Gates Foundation and later as senior advisor to Sanofi’s CEO. He has founded or co-founded five start-ups, published over 200 papers, and holds multiple patents. He has served on numerous boards, including the Lasker Foundation, Research!America, and the NIH Foundation. Among his honors are election to the U.S. National Academy of Medicine, the U.S. National Academy of Engineering, and the French Academy of Medicine, along with receiving the French Legion of Honor medal.

Member News

View All Member News
Oct 12, 2026Member News
2025 New Member Class Induction Ceremony
2025 New Member Class Induction Ceremony
Sep 15, 2026News
Terry Fulmer Receives Lienhard Award From National Academy of Medicine for Advancing Health Care for Older Adults
Terry Fulmer Receives Lienhard Award From National Academy of Medicine for Advancing Health Care for Older Adults
Sep 15, 2026News
National Academy of Medicine to Present Hamburg Award to Christine and Jonathan Seidman for Pioneering Discoveries and Treatments for Heart Muscle Diseases
National Academy of Medicine to Present Hamburg Award to Christine and Jonathan Seidman for Pioneering Discoveries and Treatments for Heart Muscle Diseases
Sep 15, 2026News
Kristine Yaffe Receives National Academy of Medicine’s Sarnat Prize for Transformative Work in Dementia Prevention and Cognitive Aging
Kristine Yaffe Receives National Academy of Medicine’s Sarnat Prize for Transformative Work in Dementia Prevention and Cognitive Aging
Jun 17, 2026Announcement
NAM Emerging Leaders Scholars Named in Honor of Departing President Victor J. Dzau
NAM Emerging Leaders Scholars Named in Honor of Departing President Victor J. Dzau
May 14, 2026Member News
Treating Political Violence as a Health Behavior We Can Change
Violence and Conflict
Treating Political Violence as a Health Behavior We Can Change
Secret Link